AIM: To estimate the hepatitis C virus (HCV) vertical transmission rate, the effect of potential risk factors, and the pattern of HCV antibody response and viremia in HCV-infected infants in Benha, Egypt. METHODS: A total of 1224 pregnant women who were treated at Benha University Hospital, Egypt, were included in the study. They completed a questionnaire about risk factors for HCV acquisition and suspected risk factors for mother-to-infant transmission and were tested for HCV antibody using a third-generation ELISA test. Women positive for HCV antibody were tested for HCV RNA by polymerase chain reaction. Peripheral blood of infants of positive HCV-RNA women was tested for HCV antibody and HCV-RNA at 1 and after 6 months of age. RESULTS: Out of 1224 pregnant women, 105 (8.6%; 95% confidence interval, 7.05-10.17) were positive for HCV antibody. Only 83 (6.8%; 5.39-7.21) were positive for HCV-RNA. HCV infection was associated with older age (1.16; 1.1-1.2, P=0.001), blood transfusion (2.69; 1.2-6.0, P=0.016), and HCV infection of the husband (5.47; 1.4-21, P=0.014) or other household members (2.29; 1.2-4.6, P=0.019). Out of 53 infants tested at first month, 43 (81%; 71-92%) were positive for HCV antibody, but only 7 (13%; 4.1-22%) were positive for HCV-RNA. After 6 months, only 2 (3.8%; 0-8.95%) remained positive for HCV RNA. CONCLUSIONS: The prevalence of HCV in pregnant women in Egypt is lower than previously reported and the potential risk factors associated with HCV infection suggest intra-familial transmission. The frequency of vertical transmission of HCV in Egypt is not substantially different from other countries and does not play a role in the high prevalence of HCV in Egypt.
AIM: To estimate the hepatitis C virus (HCV) vertical transmission rate, the effect of potential risk factors, and the pattern of HCV antibody response and viremia in HCV-infectedinfants in Benha, Egypt. METHODS: A total of 1224 pregnant women who were treated at Benha University Hospital, Egypt, were included in the study. They completed a questionnaire about risk factors for HCV acquisition and suspected risk factors for mother-to-infant transmission and were tested for HCV antibody using a third-generation ELISA test. Women positive for HCV antibody were tested for HCV RNA by polymerase chain reaction. Peripheral blood of infants of positive HCV-RNA women was tested for HCV antibody and HCV-RNA at 1 and after 6 months of age. RESULTS: Out of 1224 pregnant women, 105 (8.6%; 95% confidence interval, 7.05-10.17) were positive for HCV antibody. Only 83 (6.8%; 5.39-7.21) were positive for HCV-RNA. HCV infection was associated with older age (1.16; 1.1-1.2, P=0.001), blood transfusion (2.69; 1.2-6.0, P=0.016), and HCV infection of the husband (5.47; 1.4-21, P=0.014) or other household members (2.29; 1.2-4.6, P=0.019). Out of 53 infants tested at first month, 43 (81%; 71-92%) were positive for HCV antibody, but only 7 (13%; 4.1-22%) were positive for HCV-RNA. After 6 months, only 2 (3.8%; 0-8.95%) remained positive for HCV RNA. CONCLUSIONS: The prevalence of HCV in pregnant women in Egypt is lower than previously reported and the potential risk factors associated with HCV infection suggest intra-familial transmission. The frequency of vertical transmission of HCV in Egypt is not substantially different from other countries and does not play a role in the high prevalence of HCV in Egypt.
Authors: M Ketzinel-Gilad; S L Colodner; R Hadary; E Granot; D Shouval; E Galun Journal: Eur J Clin Microbiol Infect Dis Date: 2000-04 Impact factor: 3.267
Authors: A Ruiz-Extremera; J Salmerón; C Torres; P M De Rueda; F Giménez; C Robles; M T Miranda Journal: Pediatr Infect Dis J Date: 2000-06 Impact factor: 2.129
Authors: C Frank; M K Mohamed; G T Strickland; D Lavanchy; R R Arthur; L S Magder; T El Khoby; Y Abdel-Wahab; E S Aly Ohn; W Anwar; I Sallam Journal: Lancet Date: 2000-03-11 Impact factor: 79.321
Authors: M Habib; M K Mohamed; F Abdel-Aziz; L S Magder; M Abdel-Hamid; F Gamil; S Madkour; N N Mikhail; W Anwar; G T Strickland; A D Fix; I Sallam Journal: Hepatology Date: 2001-01 Impact factor: 17.425
Authors: F Abdel-Aziz; M Habib; M K Mohamed; M Abdel-Hamid; F Gamil; S Madkour; N N Mikhail; D Thomas; A D Fix; G T Strickland; W Anwar; I Sallam Journal: Hepatology Date: 2000-07 Impact factor: 17.425
Authors: Zelma B Costa; Gustavo C Machado; Mariza M Avelino; Clidenor Gomes Filho; Jose V Macedo Filho; Ana L Minuzzi; Marilia D Turchi; Mariane M A Stefani; Wayner Vieira de Souza; Celina Mt Martelli Journal: BMC Infect Dis Date: 2009-07-27 Impact factor: 3.090
Authors: Abeer A Bahnassy; Abdel-Rahman N Zekri; Ahmed El-Bastawisy; Amal Fawzy; Marwa Shetta; Nehal Hussein; Dalia Omran; Abdallah A S Ahmed; Samir S El-Labbody Journal: World J Gastroenterol Date: 2014-12-28 Impact factor: 5.742
Authors: Abdel-Rahman N Zekri; Abeer A Bahnassy; Mohamed M Hafez; Zeinab K Hassan; Mahmoud Kamel; Samah A Loutfy; Ghada M Sherif; Abdel-Rahman El-Zayadi; Sayed S Daoud Journal: Comp Hepatol Date: 2011-07-23
Authors: Entisar A Murad; Suad M Babiker; Gasim I Gasim; Duria A Rayis; Ishag Adam Journal: BMC Pregnancy Childbirth Date: 2013-06-07 Impact factor: 3.007